Shanghai, China

Douglas B Lowrie

This inventor holds 1 USPTO granted patent. Top assignees: Fudan University, Id Pharma Co., Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Douglas B Lowrie. Retrieved from https://idiyas.com/inventor/douglas-b-lowrie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Douglas B. Lowrie: Innovator in Vaccine Development

Introduction

Douglas B. Lowrie is a notable inventor based in Shanghai, China. He has made significant contributions to the field of vaccine development, particularly through his innovative approaches to using viral vectors.

Latest Patents

One of his key patents is titled "Anti-vaccine using Sendai virus as vector." This patent describes a recombinant Sendai virus vector vaccine that expresses immunodominant antigens. It can be utilized as both a therapeutic and preventive vaccine against tuberculosis. Douglas holds 1 patent in this area, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Douglas has worked with esteemed institutions such as Fudan University and Id Pharma Co., Ltd. His work in these organizations has allowed him to explore innovative solutions in vaccine technology and contribute to public health.

Collaborations

Douglas has collaborated with notable colleagues, including Tsugumine Shu and Zhi-Dong Hu. These partnerships have further enriched his research and development efforts in the field of immunology.

Conclusion

Douglas B. Lowrie's contributions to vaccine development highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in medical research and public health initiatives.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…